Roll Back Malaria

News

Historic moment for the global malaria community as first malaria vaccine recommended for widespread use among children in Africa

Geneva, 6 October 2021 – The RBM Partnership to End Malaria welcomes today’s historic recommendation by the World Health Organization (WHO) to scale up deployment of the first-ever malaria vaccine as a complementary prevention tool for children under 5 in sub-Saharan Africa and other regions with moderate to high P....

Read more.

RBM Partnership Board thanks outgoing and welcomes new Board Members

At its 19th Board Meeting, the RBM Partnership to End Malaria Board voted in four new Members:

  • Dr John Chimumbwa, Executive Director, Southern Africa Development Community (SADC) Malaria Elimination 8, Zambia
  • Dr Helen Jamet, Deputy Director, Vector Control,...

RBM Partnership to End Malaria Board calls for nominations

Geneva, 24 September 2021 - In line with the RBM Board Rotation Policy...

RBM Partnership welcomes new commitments to malaria innovation, including mRNA platform and local manufacturing for malaria vaccine

Geneva, 26 July 2021 -- The RBM Partnership to End Malaria welcomes the announcement today of a major project by kENUP Foundation and BioNTech to develop the first mRNA-based prophylactic malaria vaccine.

Supported by the World Health Organization (...

Featured

Upcoming Events

26 October 2021
Time of the event: 15.00-18.00 CET
27 October 2021
The RBM Partnership to End Malaria, through its Country/Regional Support Partner Committee (CRSPC...
30 October 2021
06 November 2021

Twitter

Our Latest Work

Subscribe to our Newsletter

Subscribe to the RBM newsletter to receive monthly updates from the malaria world.

Subscribe

Latest Newsletter

youtube instagram linkedin facebook twitter